|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910220124103321 |
|
|
Autore |
Mattke Soeren |
|
|
Titolo |
Medicines as a service [[electronic resource] ] : a new commercial model for big pharma in the postblockbuster world / / Soeren Mattke, Lisa Klautzer, and Tewodaj Mengistu |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Santa Monica, Calif., : RAND, c2012 |
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Edizione |
[1st ed.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (12 p.) |
|
|
|
|
|
|
Collana |
|
RAND Health occasional paper |
|
|
|
|
|
|
Altri autori (Persone) |
|
KlautzerLisa |
MengistuTewodaj |
|
|
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Pharmaceutical services |
Pharmaceutical industry |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references. |
|
|
|
|
|
|
Nota di contenuto |
|
|
|
|
|
|
Sommario/riassunto |
|
The pharmaceutical industry can reconfigure its considerable resources to develop innovative and meaningful business models that are based on services that improve access and adherence to prescription drugs for common chronic conditions. Such innovation beyond drug development is consistent with the core capabilities of large pharmaceutical companies and has the potential to achieve profit levels similar to those of its traditional models. |
|
|
|
|
|
|
|